Patent assignee · FR · COMPANY

UNIVERSITE DE STRASBOURG

🏢 View company profile →
168Patents
166Active
168Granted
60Portfolio score

Filing activity: Apr 5, 2002 → Apr 20, 2023 · 37 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8174696B2 Device for sorting and concentrating electromagnetic energy and apparatus comprising at least one such device Physics 42 Active
US8303478B2 Robotized installation for the positioning and movement of a component or instrument and treatment device that comprises such an installation Human Necessities 26 Active
US9066966B2 Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia Chemistry; Metallurgy 24 Active
US9446360B2 Microfluidic system and methods for highly selective droplet fusion Emerging Cross-Sectional Technologies 21 Active
US7618954B2 Inositol pyrophosphates, and methods of use thereof Chemistry; Metallurgy 20 Active
US10617542B2 Elastic ring and associated treatment device for implanting in a conduit for circulation of a body fluid Human Necessities 20 Active
US10660719B2 Master interface device for a motorised endoscopic system and installation comprising such a device Physics 15 Active
US10337027B2 Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia Chemistry; Metallurgy 12 Active
US8114849B2 Retinal dystrophy-associated protein and uses thereof Chemistry; Metallurgy 10 Active
US8518695B2 Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 Chemistry; Metallurgy 10 Active
US8071745B2 Polynucleotides encoding rod-derived cone viability factor (rdcvf) and methods of using the same Chemistry; Metallurgy 10 Active
US9051302B2 Synthesis of resorcylic acid lactones useful as therapeutic agents Emerging Cross-Sectional Technologies 10 Active
US8394756B2 Methods of increasing RDCVF 1 or RDCVF 2 polypeptides in retinal cells Chemistry; Metallurgy 9 Active
US8067412B2 Macrocyclic compounds useful as inhibitors of kinases and HSP90 Chemistry; Metallurgy 9 Active
US10004616B2 Treatment kit, treatment device, and associated method of production Emerging Cross-Sectional Technologies 8 Active
US7795387B2 Rod-derived cone viability factor (RDCVF) and a method of enhancing cone cell survival by RDCVF Chemistry; Metallurgy 8 Expired
US8450305B2 Macrocyclic compounds useful as inhibitors of kinases and HSP90 Chemistry; Metallurgy 8 Active
US9125734B2 Artificial retina that includes a photovoltaic material layer including a titanium dioxide semiconductor Emerging Cross-Sectional Technologies 8 Active
US8367672B2 Pyridazine compounds, compositions and methods Chemistry; Metallurgy 6 Active
US9090648B2 Cationic oligonucleotides, automated methods for preparing same and their uses Emerging Cross-Sectional Technologies 6 Active
US8628726B2 Photocatalysts based on structured three-dimensional carbide, in particular β-SiC, foams Chemistry; Metallurgy 5 Active
US8518408B2 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infection Chemistry; Metallurgy 5 Active
US8063047B2 Pyridazine compounds and methods Chemistry; Metallurgy 4 Active
US8957043B2 Methods of treating retinitis pigmentosa using nucleic acids encoding RDCVF1 or RDCVF2 Chemistry; Metallurgy 4 Active
US8088774B2 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death Chemistry; Metallurgy 4 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.